2C: Alcohol and Cancer

View the presentation slides.

A talk regarding what is known about alcohol in cancer etiology, what the recommendations are for alcohol consumption and the impact of reduction or cessation of consumption on cancer risk.

Learning Objectives:
Participants will:

  1. Identify cancer sites for which alcohol increases risk;
  2. Identity differences in guidelines for alcohol consumption from several countries and international organizations;
  3. Identify current research regarding reduction or cessation in alcohol consumption in relation to risk of cancer at several sites.

Headshot of Jo Freudenheim

Dr. Jo Freudenheim, PhD, MS, RD
SUNY Distinguished Professor and Associate Dean for Faculty Affairs, School of Public Health and Health Professions, Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo

Bio: Dr. Freudenheim was trained in Nutritional Sciences and Epidemiology at the University of Wisconsin-Madison and then did postdoctoral training in cancer epidemiology with a focus on nutrition at the University at Buffalo. A major focus of her research has been on breast cancer epidemiology, using epidemiologic tools to understand the disease at the population, individual, tissue and molecular levels in order to improve prevention and prognosis. With a long focus on diet and alcohol with regard to cancer, she was among the first to examine the interaction of folate with alcohol in relation to cancer risk. Recent research has focused on factors related to all-cause and cancer specific mortality following a breast cancer diagnosis. Her research has also included research on the impact of reduction or cessation of alcohol consumption on breast cancer risk. She has been part of national and international reviews of alcohol in relation to cancer, examining reduction and cessation of alcohol and risk as well as the association of light and moderate intakes with cancer risk. She has held leadership roles in cancer epidemiology, including membership on editorial boards for major journals in cancer epidemiology (Cancer Epidemiology, Biomarkers and Prevention, Cancer Causes and Control, Current Epidemiology Reports) and on advisory boards at the regional, national and international level (Board of Scientific Counselors of the National Cancer Institute,chair of the Molecular Epidemiology Group Steering Committee of the American Association for Cancer Research).